Debate: Is there an optimal treatment for refractory colorectal cancer? - TAS-102 or regorafenib

In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Eric Van Cutsem argues that TAS-102 or regorafenib are the optimal treatment for refractory colorectal cancer.<br /><br />Ear... Author: imedex Added: 10/13/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts